Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125478551 | 12547855 | 1 | I | 20160601 | 20160602 | 20160712 | 20160712 | PER | US-ASTRAZENECA-2016SE59742 | ASTRAZENECA | 21804.00 | DY | F | Y | 158.80000 | KG | 20160712 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125478551 | 12547855 | 1 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | 21773 | 5 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||||||
| 125478551 | 12547855 | 2 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | 21773 | 10 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||||||
| 125478551 | 12547855 | 3 | SS | FARXIGA | DAPAGLIFLOZIN PROPANEDIOL | 1 | Oral | 7310 | MG | 0 | 10 | MG | TABLET | QD | |||||
| 125478551 | 12547855 | 4 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 1000 | MG | BID | ||||||||
| 125478551 | 12547855 | 5 | C | LORSARTAN | 2 | Oral | 0 | 40 | MG | QD | |||||||||
| 125478551 | 12547855 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 0 | 40 | MG | QD | ||||||||
| 125478551 | 12547855 | 7 | C | BABY ASPIRIN | ASPIRIN | 1 | Oral | 0 | 81 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125478551 | 12547855 | 1 | Type 2 diabetes mellitus |
| 125478551 | 12547855 | 2 | Type 2 diabetes mellitus |
| 125478551 | 12547855 | 3 | Type 2 diabetes mellitus |
| 125478551 | 12547855 | 4 | Type 2 diabetes mellitus |
| 125478551 | 12547855 | 5 | Cardiac disorder |
| 125478551 | 12547855 | 6 | Peripheral swelling |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125478551 | 12547855 | Injection site haemorrhage | |
| 125478551 | 12547855 | Product quality issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125478551 | 12547855 | 1 | 2014 | 0 | ||
| 125478551 | 12547855 | 2 | 2014 | 0 | ||
| 125478551 | 12547855 | 3 | 2014 | 0 | ||
| 125478551 | 12547855 | 4 | 2014 | 0 | ||
| 125478551 | 12547855 | 5 | 2014 | 0 | ||
| 125478551 | 12547855 | 6 | 2014 | 0 | ||
| 125478551 | 12547855 | 7 | 2014 | 0 |